KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Treasury Shares (2023)

Arbutus Biopharma's Treasury Shares history spans 1 years, with the latest figure at $1.2 million for Q4 2023.

  • For Q4 2023, Treasury Shares changed N/A year-over-year to $1.2 million; the TTM value through Dec 2023 reached $1.2 million, changed N/A, while the annual FY2023 figure was $1.2 million, N/A changed from the prior year.
  • Treasury Shares for Q4 2023 was $1.2 million at Arbutus Biopharma.
  • Across five years, Treasury Shares topped out at $1.2 million in Q4 2023 and bottomed at $1.2 million in Q4 2023.